Intact and C-Terminal FGF23 Assays-Do Kidney Function, Inflammation, and Low Iron Influence Relationships With Outcomes?

被引:14
|
作者
Sharma, Shilpa [1 ,2 ]
Katz, Ronit [3 ]
Bullen, Alexander L. [4 ]
Chaves, Paulo H. M. [5 ]
de Leeuw, Peter W. [6 ,7 ]
Kroon, Abraham A. [6 ,7 ]
Houben, Alfons J. H. M. [6 ,7 ]
Shlipak, Michael G. [8 ]
Ix, Joachim H. [4 ,9 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA
[2] Vet Affairs Greater Los Angeles Healthcare Syst, Nephrol Sect, Los Angeles, CA 90073 USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Calif San Diego, Dept Med, Div Nephrol Hypertens, San Diego, CA 92103 USA
[5] Florida Int Univ, Benjamin Leon Ctr Geriatr Res & Educ, Dept Translat Med, Herbert Wertheim Coll Med, Miami, FL 33199 USA
[6] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6200 MD Maastricht, Netherlands
[7] Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands
[8] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[9] Vet Affairs San Diego Healthcare Syst, Nephrol Sect, La Jolla, CA 92161 USA
来源
关键词
FGF23; assays; mortality; inflammation; kidney function; iron deficiency; GROWTH-FACTOR; 23; STAGE RENAL-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR EVENTS; FACTOR-23; FIBROBLAST-GROWTH-FACTOR-23; PREDICTOR; MARKERS; DEATH; RISK;
D O I
10.1210/clinem/dgaa665
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Higher fibroblast growth factor-23 (FGF23) concentrations are associated with heart failure and mortality in diverse populations, but the strengths of associations differ markedly depending up on which assay is used. Objective: We sought to evaluate whether iron deficiency, inflammation, or kidney function account for differences in the strengths of associations between these 2 FGF23 assays with clinical outcomes. Design: Case cohort study from the Cardiovascular Health Study. Setting: A total of 844 community-dwelling individuals aged 65 years or older with and without chronic kidney disease were followed for 10 years. Outcomes: Outcomes included death, incident heart failure (HF), and incident myocardial infarction (MI). Exposure was baseline intact and C-terminal FGF23. Using modified Cox models, adjusting sequentially we tested whether observed associations of each assay with outcomes were attenuated by iron status, inflammation, kidney function, ortheir combinations. Results: FGF23 measured by either assay was associated with mortality in unadjusted analysis (intact FGF23 hazard ratio [HR] per 2-fold higher 1.45; 95% CI, 1.25-1.68; C-terminal FGF23 HR 1.38; 95% CI, 1.26-1.50). Adjustment for kidney function completely attenuated associations of intact FGF23 with mortality (HR 1.00; 95% CI, 0.85-1.17), but had much less influence on the association of C-terminal FGF23, for which results remained significant after adjustment (HR 1.15; 95% CI, 1.04-1.28). Attenuation was much less with adjustment for iron status or inflammation. Results were similar for the HF end point. Neither C-terminal or intact FGF23 was associated with MI risk. Conclusions: The relationship of FGF23 with clinical end points is markedly different depending on the type of FGF23 assay used. The associations of biologically active FGF23 with clinical end points may be confounded by kidney disease, and thus much weaker than previously thought.
引用
收藏
页数:11
相关论文
共 21 条
  • [1] The effect of burosumab on intact and C-terminal FGF23 measurements
    Ashrafzadeh-Kian, Susan Louise
    Ito, Nobuaki
    Srivastava, Tarak
    Garg, Uttam
    Kato, Hajime
    Algeciras-Schimnich, Alicia
    Bornhorst, Joshua A.
    CLINICAL ENDOCRINOLOGY, 2023, 99 (02) : 152 - 157
  • [2] Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements
    Smith, Edward R.
    Cai, Michael M.
    McMahon, Lawrence P.
    Holt, Stephen G.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (09): : 3357 - 3365
  • [3] C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival
    Chang Chu
    Saban Elitok
    Shufei Zeng
    Yingquan Xiong
    Carl-Friedrich Hocher
    Ahmed A. Hasan
    Bernhard K. Krämer
    Berthold Hocher
    BMC Nephrology, 22
  • [4] C-TERMINAL AND INTACT FGF23 IN KIDNEY TRANSPLANT RECIPIENTS AND THEIR ASSOCIATIONS WITH OVERALL GRAFT SURVIVAL
    Chu, C.
    Elitok, S.
    Zeng, S.
    Xiong, Y.
    Hocher, C. -F.
    Hasan, A. A.
    Kraemer, B. K.
    Hocher, B.
    TRANSPLANT INTERNATIONAL, 2021, 34 : 25 - 26
  • [5] C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival
    Chu, Chang
    Elitok, Saban
    Zeng, Shufei
    Xiong, Yingquan
    Hocher, Carl-Friedrich
    Hasan, Ahmed A.
    Kraemer, Bernhard K.
    Hocher, Berthold
    BMC NEPHROLOGY, 2021, 22 (01)
  • [6] C-terminal and intact FGF23 in critical illness and their associations with acute kidney injury and in-hospital mortality
    Rygasiewicz, Karolina
    Hryszko, Tomasz
    Siemiatkowski, Andrzej
    Brzosko, Szymon
    Rydzewska-Rosolowska, Alicja
    Naumnik, Beata
    CYTOKINE, 2018, 103 : 15 - 19
  • [7] Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation
    Courbon, Guillaume
    Thomas, Jane Joy
    Martinez-Calle, Marta
    Wang, Xueyan
    Spindler, Jadeah
    Von Drasek, John
    Hunt-Tobey, Bridget
    Mehta, Rupal
    Isakova, Tamara
    Chang, Wenhan
    Creemers, John W. M.
    Ji, Peng
    Martin, Aline
    David, Valentin
    BLOOD, 2023, 142 (01) : 106 - 118
  • [8] Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease
    Abinti, Matteo
    Vettoretti, Simone
    Caldiroli, Lara
    Mattinzoli, Deborah
    Ikehata, Masami
    Armelloni, Silvia
    Molinari, Paolo
    Alfieri, Carlo Maria
    Castellano, Giuseppe
    Messa, Piergiorgio
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [9] Iron Status Regulates Serum C-terminal FGF23 in Healthy Adult Women
    Imel, Erik
    Hui, Siu Lui
    Gray, Amie
    Acton, Dena
    Acton, Anthony
    Padgett, Leah
    Peacock, Munro
    Econs, Michael
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [10] UTILITY OF C-TERMINAL AND INTACT FGF23 IN PROGNOSTICATION OF ACUTE KIDNEY INJURY AND DEATH AMONG INTENSIVE CARE UNIT PATIENTS
    Hryszko, Tomasz
    Rygasiewicz, Karolina
    Siemiatkowski, Andrzej
    Brzosko, Szymon
    Rydzewska-Rosolowska, Alicja
    Naumnik, Beata
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33